Omega Fund IV GP, L.P.'s Net Worth

$120 Million

Who is Omega Fund IV GP, L.P.?

Omega Fund IV GP, L.P. has an estimated net worth of $120 Million. This is based on reported shares across multiple companies, which include Kezar Life Sciences, Inc., Replimune Group, Inc., Translate Bio, Inc., Paratek Pharmaceuticals, Inc., and Nuvation Bio Inc..

SEC CIK

Omega Fund IV GP, L.P.'s CIK is 0001528383

Past Insider Trading and Trends

2018 was Omega Fund IV GP, L.P.'s most active year for acquiring shares with 14 total transactions. Omega Fund IV GP, L.P.'s most active month to acquire stocks was the month of June. 2021 was Omega Fund IV GP, L.P.'s most active year for disposing of shares, totalling 27 transactions. Omega Fund IV GP, L.P.'s most active month to dispose stocks was the month of June. 2018 saw Omega Fund IV GP, L.P. paying a total of $4,000,005.00 for 11,378,705 shares, this is the most they've acquired in one year. In 2021 Omega Fund IV GP, L.P. cashed out on 813,997 shares for a total of $16,342,914.12, their largest year based on trade value.